AGC
LMDXW

Angelo Gordon & Co’s LumiraDx Limited Warrant LMDXW Stock Holding History

Angelo Gordon & Co’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-99,999
Closed -$827K – 267
2021
Q3 		$827K Buy
+99,999
New +$116K 0.05% 142

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Angelo Gordon & Co's LMDXW Position: Q4 2021 in Review

Angelo Gordon & Co sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2021, closing a stake of 99,999 shares — an estimated $827K sold.

Angelo Gordon & Co first reported a position in LMDXW in Q3 2021 and held it in 1 quarter. The position peaked at $827K in Q3 2021. 24 funds tracked by Wall St. Rank hold LMDXW as of Q4 2021.

  • Angelo Gordon & Co reported no remaining LumiraDx Limited Warrant position as of Q4 2021 after selling out during the quarter.
  • Angelo Gordon & Co sold 99,999 LumiraDx Limited Warrant shares in Q4 2021, an estimated $827K.
  • Angelo Gordon & Co first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 1 quarter.
  • Angelo Gordon & Co's LumiraDx Limited Warrant position peaked at $827K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2021.

Based on Angelo Gordon & Co's 13F filing for Q4 2021, filed 14 Feb 2022.